A new study has identified a potential biomarker in the blood that is linked to disease progression and brain inflammation in people with multiple sclerosis (MS). This discovery could lead to new ways to monitor and treat the disease.
The research was conducted by scientists at the Temerty Faculty of Medicine. They focused on analyzing blood samples from a large cohort of MS patients over time.
The study found that elevated levels of a specific protein were consistently associated with increased brain inflammation and a faster progression of disability.
If validated in further studies, this biomarker could serve several important functions in clinical practice.
The research team plans to conduct larger, longitudinal studies to confirm these findings. They also aim to investigate the biological role of the protein in the MS disease process.
This work represents a significant step toward better understanding and managing multiple sclerosis.
